Alembic Pharmaceuticals Ltd
Glimepiride (2mg) + Metformin (500mg) + Voglibose (0.mg)
Trivogo 2 Tablet SR is a combination of anti-diabetic drugs used to treat type 2 diabetes mellitus in adults, helping to control blood sugar levels.
Tablet SR
Trivogo 2 Tablet SR is a combination of three antidiabetic medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. It is a Tablet SR form.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Trivogo 2 Tablet SR is to be taken empty stomach.
No common side effects listed.
It is unsafe to consume alcohol with Trivogo 2 Tablet SR.
Trivogo 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Trivogo 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Trivogo 2 Tablet SR is a combination of three antidiabetic medicines:
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly.
Trivogo 2 Tablet SR contains Glimepiride, Metformin, and Voglibose. It's used to treat type 2 diabetes mellitus (DM). This combination helps regulate blood glucose levels in adults when combined with healthy eating habits and regular exercise. Glimepiride lowers blood glucose by increasing insulin release from the pancreas. Metformin reduces glucose production in the liver and improves insulin sensitivity. Voglibose is an alpha-glucosidase inhibitor that decreases postprandial (after meals) glucose levels.
Common side effects include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infections. If you experience any unusual symptoms or reactions, contact your healthcare professional immediately.
Trivogo 2 Tablet SR shouldn't be taken by patients with known allergies to its ingredients. It is also avoided in those with moderate to severe kidney disease, inflammatory bowel disease (IBD), colonic ulcers, and underlying metabolic acidosis including diabetic ketoacidosis.
No, combining Trivogo 2 Tablet SR with alcohol is not advised. It may lower blood sugar levels (hypoglycemia) and increase the risk of lactic acidosis.
Yes, using Trivogo 2 Tablet SR can lead to hypoglycemia (low blood sugar). Symptoms may include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. This is more likely if you miss meals, drink alcohol, over-exercise, or take other antidiabetic medications alongside it. Regular blood sugar monitoring is crucial to ensure safe treatment.
Keep this medication in its original packaging, securely sealed. Store according to the instructions on the product label or package. Do not discard the unused medicine and ensure it is inaccessible to pets, children, or unauthorized individuals.